Clinical trial
Intranasal Vasopressin Treatment in Children With Autism
NCT03204786 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intranasal Vasopressin Treatment in Children With Autism
- Lead sponsor
- Stanford University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 20, 2018
- Completion date
- March 18, 2024
- Enrollment
- 157 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
asd, autism, autism spectrum disorder